Potential Use of Cyclodextrins as Drug Carriers and Active Pharmaceutical Ingredients

被引：51
|
作者：
Arima, Hidetoshi [1 ,2 ]
Motoyama, Keiichi [1 ]
Higashi, Taishi [1 ]
机构：
[1] Kumamoto Univ, Grad Sch Pharmaceut Sci, Chuo Ku, 5-1 Oehonmachi, Kumamoto 8620973, Japan
[2] Kumamoto Univ, HIGO Hlth Life Sci Interdisciplinary & Glocal Ori, Program Leading Grad Sch, Chuo Ku, 5-1 Oehonmachi, Kumamoto 8620973, Japan
来源：
CHEMICAL & PHARMACEUTICAL BULLETIN | 2017年 / 65卷 / 04期
关键词：
cyclodextrin (CyD); drug delivery system (DDS); active pharmaceutical ingredient; non-viral vector; supramolecule; METHYL-BETA-CYCLODEXTRIN; TERNARY INCLUSION COMPLEX; SUSTAINED-RELEASE SYSTEM; PICK-C-DISEASE; IN-VITRO; ALPHA-CYCLODEXTRIN; PEGYLATED INSULIN; BIOCLEAVABLE POLYROTAXANES; FULMINANT-HEPATITIS; GAMMA-CYCLODEXTRINS;
D O I：
10.1248/cpb.c16-00779
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Cyclodextrins (CyDs) are extensively used in various fields, and especially have been widely utilized as pharmaceutical excipients and drug carriers in the pharmaceutical field. Owing to the multi -functional and biocompatible characteristics, CyDs can improve the undesirable properties of drug molecules. This review outlines the current application of CyDs in pharmaceutical formulations, focusing on their use as CyD-based drug carriers for several kinds of drugs. Additionally, CyDs have great potential as active pharmaceutical ingredients against various diseases with few side effects.
引用
收藏
页码：341 / 348
页数：8
相关论文
共 50 条
  • [31] Assessment of active pharmaceutical ingredients in drug registration procedures in Pakistan: implications for the future
    Khan, Babar
    Godman, Brian
    Babar, Ayesha
    Hussain, Shahzad
    Mahmood, Sidra
    Aqeel, Tahir
    GABI JOURNAL-GENERICS AND BIOSIMILARS INITIATIVE JOURNAL, 2016, 5 (04): : 156 - 163
  • [32] Active pharmaceutical ingredients/pharmaceutical fine chemicals in Spain
    Beaus, R
    CHIMICA OGGI-CHEMISTRY TODAY, 2005, 23 (05) : 15 - 16
  • [33] Manufacturing peptides as active pharmaceutical ingredients
    Zompra, Aikaterini A.
    Galanis, Athanassios S.
    Werbitzky, Oleg
    Albericio, Fernando
    FUTURE MEDICINAL CHEMISTRY, 2009, 1 (02) : 361 - 377
  • [34] Active pharmaceutical ingredients are big business
    Stoker, A
    TCE, 2002, (732): : 38 - 39
  • [35] Ionic Liquids as Active Pharmaceutical Ingredients
    Ferraz, Ricardo
    Branco, Luis C.
    Prudencio, Cristina
    Noronha, Joao Paulo
    Petrovski, Zeljko
    CHEMMEDCHEM, 2011, 6 (06) : 975 - 985
  • [36] Precision active pharmaceutical ingredients are the goal
    Miller, Andrew D.
    FUTURE MEDICINAL CHEMISTRY, 2016, 8 (11) : 1209 - 1238
  • [37] Active pharmaceutical ingredients and osteonecrosis of the jaw
    Orvosi Osztaly
    ORVOSI HETILAP, 2020, 161 (51) : 2176 - 2176
  • [38] RAMAN ANALYSIS OF ACTIVE PHARMACEUTICAL INGREDIENTS
    Mattley, Yvette
    CHEMICAL & ENGINEERING NEWS, 2014, : 31 - 31
  • [39] Challenges in Nanogrinding of Active Pharmaceutical Ingredients
    Bitterlich, Andre
    Laabs, Christina
    Busmann, Eike
    Grandeury, Arnaud
    Juhnke, Michael
    Bunjes, Heike
    Kwade, Arno
    CHEMICAL ENGINEERING & TECHNOLOGY, 2014, 37 (05) : 840 - 846
  • [40] Asymmetric synthesis of active pharmaceutical ingredients
    Farina, Vittorio
    Reeves, Jonathan T.
    Senanayake, Chris H.
    Song, Jinhua J.
    CHEMICAL REVIEWS, 2006, 106 (07) : 2734 - 2793
12345